KEY FINDINGS
The Europe sleep apnea therapeutics and diagnostics market is estimated to project a CAGR of 6.48% during the forecast period, 2021-2028. The growing demand for PAP devices drives market growth.
MARKET INSIGHTS
The United Kingdom, Poland, Belgium, France, Germany, Italy, Russia, and Rest of Europe, are assessed for the Europe sleep apnea therapeutics and diagnostics market growth analysis. Italy has a high prevalence of sleep apnea. The growing use of oral appliances for sleep apnea treatment and beneficial reimbursement policies propel market growth. The usage of custom-made oral appliances is attributed to the lack of medical adherence for sleep apnea. As per an Elsevier study, developing custom-made and titratable oral appliances can minimize the degree of mandibular advancement of the jaw and apneic incidences. Further, during the pandemic, the Italian Respiratory Society (IRS) and the Italian Thoracic Society (ITS) recommend using PAP devices as the second alternative.
In Russia, the pandemic has resulted in increased demands for home sleep solutions, including diagnosis, monitoring, and treatment solutions. Other laboratory services like mask fitting and in-lab titration of PAP devices further offer growth opportunities. As per the Russian Federal State Statistics Service, the incidence rate of CVD was 32.1% per 1000 people in 2018. There is a high prevalence of CVD risk factors like hypertension, diabetes, obesity, and smoking. Such factors can place the population at higher risk of sleep-disordered breathing (SDB).
COMPETITIVE INSIGHTS
Some of the leading companies in the market include Invacare Corporation, Fisher & Paykel Healthcare Corporation Limited, GE Healthcare, Itamar Medical Ltd, Medtronic Plc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
'
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. SURGING AGING POPULATION AND OBESITY
3.1.2. AWARENESS OF ILL EFFECTS OF UNTREATED SLEEP APNEA
3.1.3. SLEEP APNEA INCIDENCES
3.1.4. DEMAND FOR PORTABLE SLEEP APNEA DEVICES
3.1.5. TECHNOLOGICAL ADVANCEMENTS
3.2. KEY RESTRAINTS
3.2.1. HIGH COST OF SLEEP APNEA DEVICES
3.2.2. LACK OF REIMBURSEMENTS
3.2.3. DEARTH OF PATIENT COMPLIANCE
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. REGULATORY FRAMEWORK
4.5. SUPPLY CHAIN ANALYSIS
4.6. OPPORTUNITY MATRIX
4.7. VENDOR LANDSCAPE
5. MARKET BY PRODUCT TYPE
5.1. THERAPEUTICS
5.1.1. POSITIVE AIRWAY PRESSURE (PAP) DEVICES
5.1.2. OXYGEN DEVICES
5.1.3. MASKS AND ACCESSORIES
5.1.4. ORAL APPLIANCES
5.1.5. ADAPTIVE SERVO VENTILATION (ASV) DEVICES
5.2. DIAGNOSTICS AND MONITORING
5.2.1. POLYSOMNOGRAPHY DEVICE (PSG)
5.2.2. OXIMETER
5.2.3. ACTIGRAPHY MONITORING DEVICE
5.2.4. RESPIRATORY POLYGRAPH
5.2.5. SLEEP APNEA SCREENING DEVICE
5.2.6. OTHER DIAGNOSTICS AND MONITORING DEVICES
6. MARKET BY END-USER
6.1. HOSPITALS & SLEEP LABORATORIES
6.2. HOME CARE SETTINGS
7. GEOGRAPHICAL ANALYSIS
7.1. EUROPE
7.1.1. MARKET SIZE & ESTIMATES
7.1.2. KEY GROWTH ENABLERS
7.1.3. KEY CHALLENGES
7.1.4. KEY PLAYERS
7.1.5. COUNTRY ANALYSIS
7.1.5.1. GERMANY
7.1.5.2. FRANCE
7.1.5.3. UNITED KINGDOM
7.1.5.4. ITALY
7.1.5.5. RUSSIA
7.1.5.6. BELGIUM
7.1.5.7. POLAND
7.1.5.8. REST OF EUROPE
8. COMPETITIVE LANDSCAPE
8.1. KEY STRATEGIC DEVELOPMENTS
8.1.1. MERGERS & ACQUISITIONS
8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
8.1.3. PARTNERSHIPS & AGREEMENTS
8.1.4. BUSINESS EXPANSIONS & DIVESTITURES
8.2. COMPANY PROFILES
8.2.1. BMC MEDICAL CO LTD
8.2.2. BRAEBON MEDICAL CORPORATION
8.2.3. CADWELL INDUSTRIES INC
8.2.4. DEVILBISS HEALTHCARE LLC
8.2.5. FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
8.2.6. GE HEALTHCARE
8.2.7. INVACARE CORPORATION
8.2.8. ITAMAR MEDICAL LTD
8.2.9. KONINKLIJKE PHILIPS NV
8.2.10. MEDTRONIC PLC
8.2.11. NIHON KOHDEN CORPORATION
8.2.12. RESMED INC
8.2.13. SMITHS MEDICAL INC
8.2.14. SOMNOMEDICS GMBH
8.2.15. TELEFLEX INCORPORATED
8.2.16. VYAIRE MEDICAL INC
1. BMC MEDICAL CO LTD
2. BRAEBON MEDICAL CORPORATION
3. CADWELL INDUSTRIES INC
4. DEVILBISS HEALTHCARE LLC
5. FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
6. GE HEALTHCARE
7. INVACARE CORPORATION
8. ITAMAR MEDICAL LTD
9. KONINKLIJKE PHILIPS NV
10. MEDTRONIC PLC
11. NIHON KOHDEN CORPORATION
12. RESMED INC
13. SMITHS MEDICAL INC
14. SOMNOMEDICS GMBH
15. TELEFLEX INCORPORATED
16. VYAIRE MEDICAL INC
